(Q37906737)

25 August 2017

1 reference

title

Juvenile dermatomyositis: immunopathogenesis, role of myositis-specific autoantibodies, and review of rituximab use. (English)

1 reference

25 August 2017

0 references

1 reference

1 reference

Yvonne E Chiu

1

1 reference

25 August 2017

Dominic O Co

series ordinal

2

1 reference

25 August 2017

publication date

1 July 2011

1 reference

25 August 2017

published in

Pediatric Dermatology

1 reference

25 August 2017

volume

28

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

357-367

1 reference

US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

A systematic review of juvenile-onset clinically amyopathic dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Juvenile dermatomyositis: advances in pathogenesis, evaluation, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Vascular pathology in dermatomyositis and anatomic relations to myopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Expression of immunoreactive major histocompatibility complex products in human skeletal muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Altered cytokine expression of peripheral blood lymphocytes in polymyositis and dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

FOXP3+ regulatory T cells in the human immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

FOXP3+ T regulatory cells in idiopathic inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Role of regulatory T cells in a new mouse model of experimental autoimmune myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Difference in B cell activation between dermatomyositis and polymyositis: analysis of the expression of RP105 on peripheral blood B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Autoantibody profiles in the sera of European patients with myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

A broadened spectrum of juvenile myositis. Myositis-specific autoantibodies in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Myopathy with antibodies to the signal recognition particle: clinical and pathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-se

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Successful autologous stem cell transplantation in two patients with juvenile dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

The efficacy and safety of rituximab for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Rituximab-associated infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

Persistent maternally derived peripheral microchimerism is associated with the juvenile idiopathic inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

A novel autoantibody to a 155-kd protein is associated with dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-1470.2011.01501.X

10.1111/J.1525-1470.2011.01501.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference